ˇ
ˇ
D. Nemecková et al. / Journal of Molecular Structure 1094 (2015) 210–236
211
prepared from a number of N-benzyl-N0-alkylpiperazines were
tested for spasmolytic activity [1]. A number of piperazine quater-
nary salts were made for anthelmintic testing, some with an excel-
lent therapeutic index against Syphacia obvelata in the mouse [2]. A
novel class of piperazine quaternary salts was tested for activity
against certain nematode endoparasites such as ascaris and pin-
worms [3]. Mono-quaternary N,N-dimethylpiperazine and
di-quaternary N,N,N0-trimethylpiperazine derivatives of chitosan,
with different degrees of substitution, were investigated for anti-
bacterial activity against five strains of Gram-positive and Gram-
negative bacteria [4]. Quaternary piperazinium salts were patented
as pro-drugs in connection with parent piperazine structural
motive contained in drugs [5]. A series of long-chain piperazine
derivatives, N-alkyl-N0-methyl piperazine and their amphiphilic
salts, N-alkyl-N0-ethyl-N0-methylpiperazinium bromide, and the
related N-alkyl-N, N0-dimethylpiperazinium bromide were synthe-
sized and tested for surface activity [6]. The differential behavior of
five different mono- and di-quaternary piperazine salts, among the
18 investigated, in modulating the electro-endo-osmotic flow and
analyte separations in capillary zone electrophoresis was observed
and evaluated successfully [7]. The piperazines or cyclizines are
generally considered as ethylenediamine derivatives or cyclic
ethylenediamines and are a broad class of chemical compounds
with many important pharmacological properties. The piper-
azine-based research has attracted considerable attention in recent
years. Piperazine and substituted piperazine nuclei had constituted
an attractive pharmacological scaffold present in various potent
marketed drugs. The incorporation of piperazine is an important
synthetic strategy in drug discovery due to its easy modifiability,
proper alkalinity, water solubility, the capacity for the formation
of hydrogen bonds and adjustment of molecular physicochemical
properties [8–11]. Piperazines have the chemical similarity with
piperidine, a constituent of piperazine in the black pepper plant.
Piperazine is introduced into medicine for better solubility of uric
acid crystals [12,13]. Recently, piperazine derivatives containing
tetrazole nucleus have been reported as an antifungal agent [14].
In particular, structurally simple 1-(1-naphthylmethyl)-piperazine,
as the efflux pump inhibitor, could exert positive effect on
tetracyclines and ciprofloxacin against their resistant bacteria
[15,16]. Moreover, benzotriazole-based piperazine derivatives
and N,N0-bis(alkyloxymethyl) piperazines had moderate antibac-
terial and antifungal activities against pathogenic bacterial strains
and fungal strains [17,18]. These results once again highlighted
that piperazine core was an important backbone and prompted
us to design some active molecules with piperazine nucleus. A
broad range of biological active compounds displaying antibacter-
ial [19–22], antifungal [23], anticancer [24–26], anti-parasitic
[27,28], anti-histamin [29], psychotolytic [30] and anti-depressive
activities [31] have been also found to contain this versatile core. In
the present work we report the protocol of title AMPSs multistep
synthesis, their acid–base behavior in comparison with another
piperazine derivatives, XRD analysis, theoretical and experimental
(IR and Raman) spectra along with NBO analysis. Therefore, the
aim of this study is fully determine the molecular structure, vibra-
tional modes and wavenumbers by quantum chemical calcula-
tions. Detailed interpretations of the vibrational spectra have
been made based on the potential energy distribution.
4-carbmethoxy-piperazine-1-ium chloride were purchased from
Tau-Chem Ltd. (Slovakia) [32]. The samples of title AMPSs prepared
and purified by crystallization as presented below were dried for
further experimental use at laboratory temperature and pressure
in a drying box filled by anhydrous calcium dichloride to constant
weigh. Melting points were determined on Boetius microscope
with digital thermometer and are not corrected. Potentiometric
titrations were done by using instrument Titroline Alpha Plus
(SCHOTT, Fischer Scientific) and electrode SenTix 21 (WTW) in a
water solution. X-ray crystal data and structure refinement of
AMPSs were collected with a KUMA KM-4 kappa four-circle
diffractometer. The structure was solved by direct methods using
SHELXS86 [33] and refined on F2 for all reflections using
SHELX193 [34]. Single crystal of 1-benzyl-1-methyl-piperazine-
1,4-diium dichloride monohydrate (4a), 1-methyl-1-octade-
cylpiperazine-1,4-diium dichloride monohydrate (4b), and
1,1-dimethylpiperazine-1,4-diium chloride iodide (4c) suitable
for XRD-analysis was obtained in the form of white prisms, 4a by
crystallization from isopropyl alcohol at room temperature, 4b
by diffusion of diethyl ether into the solution of 4b in DMF, 4c by
crystallization from ethanol at room temperature. The AMPSs crys-
tallographic data have been deposited with the Cambridge
Crystallographic Data Center as supplementary publications num-
ber CCDC 831892 (4a), 831894 (4b), and 831893 (4c), respectively.
The NMR spectra, both 1H- and 13C NMR, were acquired on a
Bruker Avance 500/100 MHz spectrometer. Chemical shifts (d)
are reported in ppm. Gas chromatography was acquired at
Shimadzu GC-17A. MALDI TOF mass spectra were measured on
an AXIMA CFR mass spectrometer from Kratos Analytical Ltd.
(Manchester, United Kingdom) equipped with a nitrogen laser
wavelength of 337 nm from Laser Science Inc. of Franklin
(Franklin, MA, USA). 2,5-Dihydroxybenzoic acid (DHB) matrices
were tried for MALDI TOF measurement. Red phosphorus was used
for external calibration [35].
The FT-IR spectra (Figs. 1–3) of AMPSs 4a–4c were recorded
using Genesis (Unicam Mattson) spectrometer, measurement of
samples in potassium bromide pellets. The FT-Raman spectrum
(Figs. 4–6) was obtained on a Bruker, Equinox 55/s spectrometer
with FRA Raman socket, 106/s. For a excitation of the spectrum
the emission of the Nd:YAG laser was used, excitation wavelength
1064 nm, maximal power 500 mV, measurement of solid samples.
All the expanded experimental spectra are given in Figs. S1–S6 as
supporting materials.
Synthesis
4-Carbmethoxypiperazine-1-ium chloride (1)
Compound was prepared by the described procedure [36], i.e.
by reaction of methyl chloroformate with piperazine in acetic acid
solution at room temperature under catalysis by Cu(II) cation sup-
ported on weak acidic cation-exchanger of polyacrylic type, pre-
paration of catalyst in [37]. Yield, m.p. and other characteristics
agreed on described ones.
1-Benzyl-4-carbmethoxypiperazine (2a)
The mixture containing 1 (9.0 g, 50 mmol), benzyl chloride
(7.0 g, 55 mmol), 10 mol% of sodium iodide as catalyst, potassium
carbonate (13.8 g, 100 mmol) in 50 mL of DMF was heated at
80 °C over a period of 8 h. Reaction course was monitored by
TLC. Thereafter the mixture was cooled to room temperature,
solids were filtered off by suction and DMF evaporated in vacuum.
The residuum was mixed with 20 mL of dry diethyl ether and solu-
tion was filtered with 100 mg of silica gel. It was obtained 10.8 g
(92%) of 1-benzyl-4-carbmethoxypiperazine as yellowish syrup
liquid, Purity by GC 96.8%.
Experimental
General
All used chemicals for syntheses were purchased from Sigma–
Aldrich (Germany) in ACS reagent grade or ReagentPlusÒ and were
used without further purification, catalyst, i.e. Cu(II) cation sup-
ported on weak acidic cation-exchanger of polyacrylic type, and